Japan-based Fujifilm has partnered with Indian pharmaceutical firm Dr Reddy’s Laboratories and Global Response Aid (GRA) in Dubai to enable international access to Avigan (favipiravir) as a potential Covid-19 treatment.

Fujifilm Toyama Chemical entered into a tripartite licensing agreement with Dr Reddy’s and GRA for the development, manufacture and sales of Avigan tablets.

Under the agreement, Dr Reddy’s and GRA gain exclusive right to develop, manufacture and sell the drug overseas, excluding China and Russia. Only Dr Reddy’s secured the manufacturing rights.